Top

Published in:

03-01-2021 | Scintigraphy | IMAGES THAT TEACH

Nuclear imaging in cardiac paragangliomas: Diagnostic and follow-up

Authors: María Belén Tagliatori-Nogueira, MD, Cristina Sandoval-Moreno, MD, María del Carmen Colomés-Íess, MD, Luis Bañuelos-Andrio, MD, PhD, Alberto Herrero-Muñoz, MD, María Ángeles Balsa-Bretón, MD

Published in: Journal of Nuclear Cardiology | Issue 5/2022

Excerpt

Paragangliomas are chromaffin cell tumors. They are located in the adrenal medulla in 90% of the cases and in the mediastinum in < 2% of the cases (< 1% of primary cardiac tumors).1 Most cases are due to mutations of one of three genes (SDHB, SDHC, and SDHD) encoding for subunits of succinate dehydrogenase (SDH) or mitochondrial complex II.2 …

Arcos L, Bustos J, Acuna J, Cely A, Forero J, Jaimes C. Cardiac paraganglioma: Advantages of cardiovascular multimodality imaging. CASE (Phila) 2018;2:266-72.

Oleaga A, Goñi F. Feocromocitoma: actualización diagnóstica y terapéutica. Endocrinol Nutr 2008;55:202-16.CrossRef

Almenieir N, Karls S, Derbekyan V, Lisbona R. Nuclear imaging of cardiac paraganglioma. J Nucl Med Technol 2017;45:247-8.CrossRef

Tam DY, Cusimano RJ. Cardiac paraganglioma. CMAJ 2017;189:E996.CrossRef

Taïeb D, Neumann H, Rubello D, Al-Nahhas A, Guillet B, Hindié E. Modern nuclear imaging for paragangliomas: Beyond SPECT. J Nucl Med 2012;53:264-74.CrossRef

Sánchez-Pacheco Tardón M, Serrano Corredor S, Carrión A, Mauri M, Yuste A. Diagnóstico tardío de un caso índice de síndrome paraganglioma/feocromocitoma asociado a la SDH. Endocrinol Nutr 2011. https://doi.org/10.1016/j.endonu.2011.07.013.CrossRefPubMed

Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, François Plouin P, Jeunemaitre X. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant pheochromocytomas. Cancer Res 2003;63:5615-21.PubMed

Timmers HJ, Chen CC, Carrasquillo JA, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2009;94:4757-67.CrossRef

Title: Nuclear imaging in cardiac paragangliomas: Diagnostic and follow-up
Authors: María Belén Tagliatori-Nogueira, MD
Cristina Sandoval-Moreno, MD
María del Carmen Colomés-Íess, MD
Luis Bañuelos-Andrio, MD, PhD
Alberto Herrero-Muñoz, MD
María Ángeles Balsa-Bretón, MD
Publication date: 03-01-2021
Publisher: Springer International Publishing
Keyword: Scintigraphy
Published in: Journal of Nuclear Cardiology / Issue 5/2022
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-020-02454-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nuclear imaging in cardiac paragangliomas: Diagnostic and follow-up

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2022

Prognostic value of heart rate reserve in patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging

Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis

Accounting for residual activity in the estimate of myocardial blood flow with PET

Integration of quantitative absolute myocardial blood flow estimates from dynamic CZT-SPECT improves the detection of coronary artery disease

Transient multifocal pulmonary uptake of 99mTc-sestamibi in myocardial perfusion imaging: Iatrogenic clot artifact

Identifying CRT responders: Moving from electrical to mechanical dyssynchrony